VCAN and lung adenocarcinoma: As the increased levels of THSB2, VCAN, and TNC on sEVs were found to indicate lung adenocarcinoma patients, we combined these biomarkers and explored their usage as a signature in identifying malignant and benign lung lesions.[14]